Tumor-associated macrophages (TAMs) are increasingly investigated in cancer immunology
and are considered a promising target for better and tailored treatment of malignant growth …

Advances in preclinical molecular imaging have generated new opportunities to
noninvasively visualize the biodistribution and tumor targeting of nanoparticle therapeutics …

Radiolabeling of nanoparticles (NPs) has been performed for a variety of reasons, such as
for studying pharmacokinetics, for imaging, or for therapy. Here, we describe the in vitro and …

Objectives: The goal of this study was to develop and validate a noninvasive imaging tool to
visualize the in vivo behavior of high-density lipoprotein (HDL) by using positron emission …

Nanocarriers can selectively target cancer sites and carry payloads, thereby improving
diagnostic and therapeutic effectiveness and reducing toxicity. The objective of this study …

Tumor associated macrophages (TAM) are key players in the cancer microenvironment.
Molecular imaging modalities such as MRI and PET can be used to track and monitor TAM …

Background The significant progress in nanotechnology provides a wide spectrum of
nanosized material for various applications, including tumor targeting and molecular …

Solid lipid nanoparticles (SLNs) are submicrometer (1− 1000 nm) colloidal carriers
developed in the past decade as an alternative system to traditional carriers (emulsions …

Deposition of liposomal drugs into solid tumors is a potentially rate-limiting step for drug
delivery and has substantial variability that may influence probability of response. Tumor …

Liposomal nanoparticles are versatile drug delivery vehicles that show great promise in
cancer therapy. In an effort to quantitatively measure their in vivo pharmacokinetics, we …